Hepatocellular carcinoma
Hepatocellular carcinoma is a primary hepatic cancer derived from well-differentiated hepatocytes. It is more frequent in adults than in childhood. Symptoms are hepatic mass, abdominal pain and, in advanced stages, jaundice, cachexia and liver failure.
class Information
definition_citation
Orphanet
has_age_of_onset
All ages
has_dbxref
- ICD-10:C22.0
- ICD-11:2C12.02
- MedDRA:10049010
- MeSH:D006528
- OMIM:114550
- UMLS:C2239176
has_inheritance
Not applicable
notation
Clinical group
present_in
- Africa AND has_annual_incidence_average_value : 16.0 AND has_annual_incidence_range : 1-5 / 10 000
- Austria AND has_annual_incidence_average_value : 5.296 AND has_annual_incidence_range : 1-9 / 100 000
- Belgium AND has_annual_incidence_average_value : 2.275 AND has_annual_incidence_range : 1-9 / 100 000
- Bulgaria AND has_annual_incidence_average_value : 1.697 AND has_annual_incidence_range : 1-9 / 100 000
- Canada AND has_annual_incidence_average_value : 5.0 AND has_annual_incidence_range : 1-9 / 100 000
- China AND has_annual_incidence_average_value : 35.0 AND has_annual_incidence_range : 1-5 / 10 000
- Croatia AND has_annual_incidence_average_value : 2.762 AND has_annual_incidence_range : 1-9 / 100 000
- Czech Republic AND has_annual_incidence_average_value : 2.979 AND has_annual_incidence_range : 1-9 / 100 000
- Estonia AND has_annual_incidence_average_value : 1.487 AND has_annual_incidence_range : 1-9 / 100 000
- Europe AND has_annual_incidence_average_value : 3.221 AND has_annual_incidence_range : 1-9 / 100 000
- Europe AND has_point_prevalence_average_value : 15.0 AND has_point_prevalence_range : 1-5 / 10 000
- Finland AND has_annual_incidence_average_value : 3.382 AND has_annual_incidence_range : 1-9 / 100 000
- France AND has_annual_incidence_average_value : 6.264 AND has_annual_incidence_range : 1-9 / 100 000
- Germany AND has_annual_incidence_average_value : 5.129 AND has_annual_incidence_range : 1-9 / 100 000
- Greece AND has_annual_incidence_average_value : 15.0 AND has_annual_incidence_range : 1-5 / 10 000
- Iceland AND has_annual_incidence_average_value : 1.278 AND has_annual_incidence_range : 1-9 / 100 000
- Ireland AND has_annual_incidence_average_value : 1.045 AND has_annual_incidence_range : 1-9 / 100 000
- Italy AND has_annual_incidence_average_value : 9.266 AND has_annual_incidence_range : 1-9 / 100 000
- Japan AND has_annual_incidence_average_value : 29.0 AND has_annual_incidence_range : 1-5 / 10 000
- Korea, Republic of AND has_annual_incidence_average_value : 49.0 AND has_annual_incidence_range : 1-5 / 10 000
- Latin America AND has_annual_incidence_average_value : 12.5 AND has_annual_incidence_range : 1-5 / 10 000
- Latvia AND has_annual_incidence_average_value : 1.933 AND has_annual_incidence_range : 1-9 / 100 000
- Lithuania AND has_annual_incidence_average_value : 1.146 AND has_annual_incidence_range : 1-9 / 100 000
- Mongolia AND has_annual_incidence_average_value : 99.0 AND has_annual_incidence_range : 6-9 / 10 000
- Netherlands AND has_annual_incidence_average_value : 1.127 AND has_annual_incidence_range : 1-9 / 100 000
- Norway AND has_annual_incidence_average_value : 1.627 AND has_annual_incidence_range : 1-9 / 100 000
- Oceania AND has_annual_incidence_average_value : 5.0 AND has_annual_incidence_range : 1-9 / 100 000
- Poland AND has_annual_incidence_average_value : 0.925 AND has_annual_incidence_range : 1-9 / 1 000 000
- Portugal AND has_annual_incidence_average_value : 2.345 AND has_annual_incidence_range : 1-9 / 100 000
- Slovakia AND has_annual_incidence_average_value : 2.762 AND has_annual_incidence_range : 1-9 / 100 000
- Spain AND has_annual_incidence_average_value : 5.212 AND has_annual_incidence_range : 1-9 / 100 000
- Switzerland AND has_annual_incidence_average_value : 6.649 AND has_annual_incidence_range : 1-9 / 100 000
- United Kingdom AND has_annual_incidence_average_value : 2.106 AND has_annual_incidence_range : 1-9 / 100 000
- United States AND has_annual_incidence_average_value : 6.2 AND has_annual_incidence_range : 1-9 / 100 000